Yes. InnoSyn is owned by private equity investor Merieux Equity Partners.
InnoSyn is headquartered in Geleen, Netherlands.
InnoSyn has 60 employees.
InnoSyn is a life science company.
InnoSyn was founded in 2017.
InnoSyn is applying innovative and cost-efficient technologies such as flow chemistry, bio- and chemocatalysis, to advance the competitiveness of customers across the (fine) chemical industries. InnoSyn was founded in 2017 and is based in Geleen, Netherlands.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
